Medicare & Medicaid

Articles for Medicare & Medicaid

Coverage of our peer-reviewed research in the healthcare and mainstream press.
Research published in the Journal of Oncology Practice has identified high treatment burden among Medicare patients with early-stage non–small cell lung cancer (NSCLC).
If the Affordable Care Act is repealed, providers of the Diabetes Prevention Program will need to replace the path to Medicare reimbursement that were covered in the law.
Researchers have found that accountable care organizations with a higher proportion of minority patients tend to score worse on Medicare’s quality performance measures.
Elderly Medicare Advantage members with multiple chronic conditions attained a survival benefit from more cost-effective care when a private plan developed gainshare and monetary risk-bearing arrangements with its contracted providers.
The study observed significant shifts in the treatment of advanced-stage non-small cell lung cancer (NSCLC), accompanied by only modest gains in survival and total Medicare spending.
The addition of new a chief medical officer and a new chief commercial officer comes as the digital health provider is poised to scale up delivery of the National Diabetes Prevention Program in Medicare.
Payments for catastrophic coverage under Medicare Part D have more than tripled since 2010, rising past $33 billion in 2015, according to a new report from the Office of Inspector General (OIG). The report identified high-priced specialty drugs as a major driver of the increase in spending.
COPD Compendium
Diabetes Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Know Your News
HF Compendium